Dendreon: Targeting Cancer, Transforming Lives
 
Upcoming Events
Feb 9, 2010
2:00 PM ET 		12th Annual BIO CEO & Investor Conference
Listen to webcast
Show Additional Information
Reminder Remind me
Feb 22, 2010
4:30 PM ET 		Q4 2009 Dendreon Earnings Conference Call
Listen to webcast
Reminder Remind me

Archived Events
Jan 11, 2010
3:00 PM PT 		28th Annual J.P. Morgan Healthcare Conference
Listen to webcast
Show Additional Information
Dec 15, 2009
10:00 AM ET 		Deutsche Bank Securities Biotech Boston Confab Conference
Listen to webcast
Show Additional Information
Dec 1, 2009
9:30 AM UK 		Dendreon Corporation Presents at NASDAQ OMX 23rd Investor Program
Listen to webcast
Nov 17, 2009
10:55 AM ET 		Lazard Capital Markets 6th Annual Healthcare Conference
Listen to webcast
Show Additional Information
Nov 13, 2009
11:30 AM ET 		Credit Suisse 2009 Healthcare Conference
Listen to webcast
Show Additional Information
Nov 11, 2009
4:30 PM ET 		Dendreon Corporation Third Quarter 2009 Financial Results
Listen to webcast
Nov 10, 2009
11:00 AM ET 		Merriman Investor Summit 2009
Listen to webcast
Show Additional Information
Sep 24, 2009
8:45 AM ET 		Dendreon Corporation Analyst Day Webcast
Listen to webcast
PDF View Presentation  3.5 MB
Sep 23, 2009
1:00 PM ET 		UBS Global Life Sciences Conference
Listen to webcast
Sep 16, 2009
1:30 PM ET 		16th Annual BioCentury NewsMakers in the Biotech Industry Conference
Listen to webcast
Sep 15, 2009
8:35 AM ET 		Morgan Stanley Global Healthcare Conference
Listen to webcast
Sep 9, 2009
4:05 PM ET 		Rodman & Renshaw 11th Annual Health Care Conference
Listen to webcast
Aug 11, 2009
8:30 AM PT 		Dendreon Corporation Second Quarter 2009 Financial Results
Listen to webcast
Apr 28, 2009
2:30 PM PT 		IMPACT Final Data Conference Call from AUA
Listen to webcast
PDF View Presentation 190.1 KB
Apr 14, 2009
9:00 AM ET 		IMPACT Data Conference Call
Listen to webcast
Oct 6, 2008
9:00 AM ET 		Dendreon Conference Call - Interim Results of IMPACT Trial
Listen to webcast


Nicole Provost, Ph.D., vice president of product development, recently presented the results of potency testing for PROVENGE at the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee Meeting. The purpose of the committee meeting was to discuss Potency Measurement for Cell and Gene Therapy Products. The full presentation is available at the following links:
Slides
Meeting Transcript